rucaparib Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Male only (1)
Any (1)

Phase 1/2 (1)
Phase 2 (1)

Interventional (2)

Brown University (1)
Gustave Roussy, Cancer Campus, Grand Paris (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadcancer

I am/have/hadmeasurable disease

I am/have/hadgilbert's syndrome

I am/have/hadpalb2

I am/have/hadabsolute neutrophil count

I am/have/hadplatelet count

I am/have/hadmetastatic disease

I am/have/hadblood transfusion

I am/have/hadrad51c

I am/have/hadhyperbilirubinemia

I am/have/hadcarcinoma

I am/have/hadcarcinoma of the prostate

I am/have/hadprogesterone

I am/have/hadliver metastasis

I am/have/hadprostate cancer

I am/have/hadsolid tumor

I am/have/hadmetastatic castration-resistant prostate cancer

I am/have/hadprogressive disease

I am/have/hadcastration-resistant prostate cancer

I am/have/hadct scan

added new label for I am/have/had

I am looking for

I am looking forrucaparib

I am looking forparp inhibitor

I am looking forpalb2

I am looking forrad51c

I am looking forprogesterone

I am looking forandrogen

I am looking fortestosterone

I am looking forgnrh

I am looking forlipase

I am looking forenzalutamide

I am looking forppp2r2a

I am looking forhba1c

I am looking fortaxane

I am looking forwarfarin

I am looking forlhrh

I am looking forapalutamide

I am looking forcolony stimulating factor

I am looking forestrogen

I am looking forgranulocyte colony stimulating factor

I am looking forglycosylated hemoglobin

added new label for I am looking for

Advanced Filters

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 1000s
Interventional Study
all
Recruiting

Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors

The primary objective of the trial is to evaluate the antitumor activity of atezolizumab and rucaparib in patients with selected advanced solid tumors as measured by the Overall Response Rate

solid neoplasm

measurable disease

solid tumor

estrogen

blood transfusion

0 views
19 Feb, 2024
1 location

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Males
Recruiting

A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer

Patients will be treated with the combination of copanlisib and rucaparib for as long as the patient does not have clinically significant progressive disease and/or unacceptable toxicity and/or as long as the investigator deems that the patient is benefiting from treatment.

small cell carcinoma of the prostate

measurable disease

ejection fraction

enzalutamide

lipase

0 views
19 Feb, 2024
1 location